Articles that cite this article:
Vaccines against myasthenia gravis
Sonia Berrih-aknin, Sara Fuchs, Miriam C Souroujon
ebot 5(7):983. doi:10.1517/14712598.5.7.983 [CrossRef]
Nasal Administration of Synthetic Acetylcholine Receptor T Epitopes Affects the Immune Response to the Acetylcholine Receptor and Prevents Experimental Myasthenia Gravisa
PETER I. Karachunski, NORMA S. Ostlie, DAVID K. Okita, BIANCA M. Conti-fine
Ann N Y Acad Sci 841(1 myasthenia gr):560. doi:10.1111/j.1749-6632.1998.tb10983.x [CrossRef]
Mapping myasthenia gravis–associated T cell epitopes on human acetylcholine receptors in HLA transgenic mice
Huan Yang, Elzbieta Goluszko, Chella David, David K. Okita, Bianca Conti-fine, Teh-sheng Chan, Mathilde A. Poussin, Premkumar Christadoss
J Clin Invest 109(8):1111. doi:10.1172/JCI14255 [CrossRef]
Heat-shock protein T-cell epitopes trigger a spreading regulatory control in a diversified arthritogenic T-cell response
Willem Eden, Ruurd Zee, Leonie S. Taams, A. Berent J. Prakken, Joel Roon, Marca H. M. Wauben
Immunol Rev 164(1):169. doi:10.1111/j.1600-065X.1998.tb01218.x [CrossRef]
Immune response of the coeliac nasal mucosa to locally-instilled gliadin
P. Torre, S. Fusco, F. Quaglia, M. L. LA Rotonda, F. Paparo, M. Maglio, R. Troncone, L. Greco
Clin Exp Immunol 127(3):513. doi:10.1046/j.1365-2249.2002.01760.x [CrossRef]
Acetylcholine receptors and myasthenia
Jon M. Lindstrom
Muscle Nerve 23(4):453. doi:10.1002/(SICI)1097-4598(200004)23:4<453::AID-MUS3>3.0.CO;2-O [CrossRef]
Amphipathic variable region heavy chain peptides derived from monoclonal human Wegener's anti-PR3 antibodies stimulate lymphocytes from patients with Wegener's granulomatosis and microscopic polyangiitis
E. Peen, C. Malone, C. Myers, R. C. Williams jr, A. B. Peck, E. Csernok, W. L. Gross, R. Staud
Clin Exp Immunol 125(2):323. doi:10.1046/j.1365-2249.2001.01482.x [CrossRef]
Reduction of human anti-tetanus toxoid antibody in hu-PBL-SCID mice by immunodominant peptides of tetanus toxoid
D. J. Jackson, C. J. Elson, B. M. Kumpel
Clin Exp Immunol 137(2):245. doi:10.1111/j.1365-2249.2004.02521.x [CrossRef]
Peptide-based therapeutic vaccines for allergic and autoimmune diseases
Mark Larché, David C Wraith
Nat Med 11(4s):S69. doi:10.1038/nm1226 [CrossRef]
Reactivity of T cells from women with antibodies to the human platelet antigen (HPA)-1a to peptides encompassing the HPA-1 polymorphism
D. J. Jackson, M. F. Murphy, P. W. Soothill, G. F. Lucas, C. J. Elson, B. M. Kumpel
Clin Exp Immunol 142(1):92. doi:10.1111/j.1365-2249.2005.02903.x [CrossRef]
Peptide-based immunotherapy: a novel strategy for allergic disease
F Runa Ali, Mark Larche
Expert Rev Vaccines 4(6):881. doi:10.1586/14760584.4.6.881 [CrossRef]
Characterization of the alloreactive helper T-cell response to the platelet membrane glycoprotein IIIa (integrin-beta3) in human platelet antigen-1a alloimmunized human platelet antigen-1b1b women
Hosea Sukati, Hagop Bessos, Robert N. Barker, Stanislaw J. Urbaniak
Transfusion (Malden) 45(7):1165. doi:10.1111/j.1537-2995.2005.00188.x [CrossRef]
Myasthenia gravis: past, present, and future
Bianca M. Conti-fine, Monica Milani, Henry J. Kaminski
J Clin Invest 116(11):2843. doi:10.1172/JCI29894 [CrossRef]
Coaxing the liver into preventing autoimmune disease in the brain
Brad E. Hoffman, Roland W. Herzog
J Clin Invest doi:10.1172/JCI37079 [CrossRef]